Tempus AI, Inc.

TEM

Precision medicineBiotech & pharmaceuticalsHealthcare diagnostics

$68.11vs prev close▼-4.58(-6.30%)

$40.7752W Range$104.32

43% from low

+26.71 (+62.57%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

2 buys

Concentrated buys

1M net buy

+$2.9M

≈ +58K shares

Portfolio Weight

3.21%

1M -0.59%p

Holding ETFs

2 ETFs

ARKG · ARKK

Sell · Weight Down

ARK net-sold the stock and the price fell, decreasing its portfolio weight.

Shares -1.0% · Market value -23.8% · Weight -0.59%p

Trade Intensity

Minor adjustment

Basis: weight -0.59%p decrease

Trade Log2-day BUY streak

Date	Action	ETF	Shares	Close	Est. total
26.08.18	BUY	ARKG	35,501	$49.36	$1.8M
26.08.17	BUY	ARKG	22,666	$51.64	$1.2M
26.07.20	BUY	ARKG · ARKK	188,785	$48.41	$9.1M
26.07.10	BUY	ARKG	28,276	$58.23	$1.6M
26.06.26	BUY	ARKG	14,601	$56.14	$819.7K
26.06.25	BUY	ARKG	49,594	$54.87	$2.7M
26.06.24	BUY	ARKG	21,275	$51.94	$1.1M
26.05.27	BUY	ARKG	25,910	$47.17	$1.2M
26.05.11	BUY	ARKG · ARKK	162,765	$48.46	$7.9M
26.05.07	BUY	ARKG · ARKK	155,045	$49.47	$7.7M
26.05.06	BUY	ARKG · ARKK	145,794	$53.50	$7.8M
26.03.26	BUY	ARKG · ARKK	60,973	$45.53	$2.8M
26.03.25	BUY	ARKG · ARKK	84,939	$46.76	$4.0M
26.03.12	BUY	ARKG	18,820	$49.53	$932.2K
26.03.11	BUY	ARKG	23,086	$52.68	$1.2M

08.18BUY

35,501

ARKGClose$49.36Est. total$1.8M

08.17BUY

22,666

ARKGClose$51.64Est. total$1.2M

07.20BUY

188,785

ARKG · ARKKClose$48.41Est. total$9.1M

07.10BUY

28,276

ARKGClose$58.23Est. total$1.6M

06.26BUY

14,601

ARKGClose$56.14Est. total$819.7K

06.25BUY

49,594

ARKGClose$54.87Est. total$2.7M

06.24BUY

21,275

ARKGClose$51.94Est. total$1.1M

05.27BUY

25,910

ARKGClose$47.17Est. total$1.2M

05.11BUY

162,765

ARKG · ARKKClose$48.46Est. total$7.9M

05.07BUY

155,045

ARKG · ARKKClose$49.47Est. total$7.7M

05.06BUY

145,794

ARKG · ARKKClose$53.50Est. total$7.8M

03.26BUY

60,973

ARKG · ARKKClose$45.53Est. total$2.8M

03.25BUY

84,939

ARKG · ARKKClose$46.76Est. total$4.0M

03.12BUY

18,820

ARKGClose$49.53Est. total$932.2K

03.11BUY

23,086

ARKGClose$52.68Est. total$1.2M

1 / 9

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

8,512,603

Portfolio Weight

3.21%

in ETF 6.54%

Est. Value

$398M

30D Net

+$14M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Strong Buy

Buy

Hold

Sell

Analyst Targets

avg.

$62.64

vs Current ▲ +2.3% upside

Current$61.25

Low ~ High$35.00 ~ $100.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Piper Sandler

Neutral

$56.00

-8.57%

—

Maintain

2026-08-04

BTIG

Buy

$70.00

+14.29%

—

Maintain

2026-08-03

HC Wainwright & Co.

Buy

$56.00

-8.57%

—

Maintain

2026-08-03

Stifel

Hold

$50.00

-18.37%

—

Maintain

2026-08-03

Needham

Buy

$75.00

+22.45%

—

Maintain

2026-07-31

1 / 4

Avg Target

$62.64

vs Current ▲ +2.3% upside

Buy

16 analysts

Strong Buy 1Buy 7Hold 7Sell 1

Low $35.00

Current $61.25

High $100.00

Firm	Position	Target	Upside	Close	Action	Date
Piper Sandler	Neutral	$56.00	-8.57%	—	Maintain	26.08.04
BTIG	Buy	$70.00	+14.29%	—	Maintain	26.08.03
HC Wainwright & Co.	Buy	$56.00	-8.57%	—	Maintain	26.08.03
Stifel	Hold	$50.00	-18.37%	—	Maintain	26.08.03
Needham	Buy	$75.00	+22.45%	—	Maintain	26.07.31

1 / 4

Price Information

Previous Close$72.69

Open$65.74

Day Range$65.25 - $72.96

52-Week Range$40.77 - $104.32

1-Year Change-4.23%

Trading Volume

Volume15,877,153

Avg Volume (3mo)6,624,264

Valuation

Market Cap13.1B

Book Value$2.47

Shares Outstanding175,390,967

Financials

Revenue (TTM)1.4B

Net Income-254,424,992

EPS$-1.44

EBITDA-193,363,008

Profitability

P/E Ratio-

P/B Ratio29.42

Return on Equity (ROE)-67.44%

Return on Assets (ROA)-8.55%

Profit Margin-17.77%

EV/EBITDA-71.08

Beta3.58

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)82.36

Company Overview

Tempus AI is a healthcare technology company that provides advanced molecular diagnostics and pathology testing, including next-generation sequencing and PCR profiling. They offer a comprehensive data library and analytical services for pharmaceutical and biotech companies, alongside clinical trial matching and research platforms. Tempus AI positions itself as a leader in precision medicine by integrating clinical, molecular, and imaging data to accelerate drug discovery and improve patient care.

P/B

29.42

High valuation

ROE

-67.4%

Persistent loss

Beta

3.58

Extreme volatility

RSI(14)

82.4

Overbought

AI-generated summary. Not investment advice.

Tempus AI, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks